Study of muscle tiredness in congenital myopathies
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 2 years or older for the general part, or 8 to 60 for the muscle tiredness part.
- You need a genetic diagnosis of a congenital myopathy (like central core disease/multiminicore disease, nemaline myopathy, or centronuclear myopathy).
- You must speak Dutch.
- You need to be able to travel to the study centers in Nijmegen or Utrecht.
- You must be willing and able to complete all measurements.
- For the tiredness part only: you may need to stop certain medicines (pyridostigmine or salbutamol) 24 hours before your visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks the health of people with nemaline myopathy over time to learn more about how the condition progresses. By joining, you help researchers understand the disease better, which may support future care and treatment development.
This research study looks at genes and molecules to better understand congenital myopathies (birth-related muscle weakness). It may help explain the cause of symptoms and improve future diagnoses for you and your family.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
This study creates a network to gather information about people with nemaline myopathy, a genetic muscle disorder. It aims to improve understanding and support for future research and care.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study looks at how to best measure muscle health and function in children with myotonic dystrophy. It may help prepare for future treatment trials.
Hear when a new Central Core Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.